PURPOSE: Lung cancer screening guidelines generally recommend imaging surveillance rather than tissue sampling for nodules measuring ≤8 mm. Evidence regarding the feasibility, diagnostic performance, and safety of tissue biopsy in this lesion size remains limited. We evaluated the diagnostic performance and safety of shape-sensing robotic-assisted bronchoscopy (ssRAB) for biopsy of peripheral pulmonary nodules measuring ≤8 mm. METHODS: We conducted a retrospective single-center study of consecutive patients who underwent ssRAB between June 2020 and December 2025 for biopsy of nodules measuring ≤8 mm on pre-procedural CT imaging. The primary outcome was strict diagnostic yield, as defined by the American Thoracic Society/American College of Chest Physicians. Secondary objectives included intermediate diagnostic yield, diagnostic distribution, procedural outcomes, and complications. Diagnostic performance according to lesion size (≤ 6 mm vs. 6.1-8 mm) was evaluated separately as a subgroup analysis. RESULTS: A total of 195 nodules were included in the study. Median lesions diameter was seven mm (IQR 6-8). Strict diagnostic yield was 70.2% (137/195), while intermediate diagnostic yield was 77.4% (151/195). Malignancy was identified in 104 lesions (53.3%). The median ssRAB procedure time was 59 min (IQR 45-83). Pneumothorax occurred in six patients (3.3%), with chest tube placement required in two (1.1%). DISCUSSION: Shape-sensing robotic-assisted bronchoscopy demonstrated meaningful diagnostic performance and a favorable safety profile for peripheral pulmonary nodules measuring ≤8 mm, including lesions ≤6 mm. In this selected, higher-risk cohort, our findings suggest that earlier tissue diagnosis can be feasible and may benefit some patients.
This case highlights the diagnostic and management challenges of refractory multisystem sarcoidosis progressing over a two-year period despite advanced biologic therapy.
Clinicians should note that the presence of targetable mutations in non-small cell lung cancer with malignant pleural disease is not associated with improved survival, based on the findings from this study.
Up nextJournal of Thoracic DiseaseOct 30, 2026Read
This study introduces ultrasound-guided trans-cannula cryobiopsy of supraclavicular lymph nodes as a novel superficial lymph node approach for tissue acquisition in 10 consecutive patients, though specific numeric success or safety results were not provided in the abstract.
Active infection is not an absolute contraindication to endobronchial valve placement, but positive pressure ventilation significantly increases clinical failure odds with an aOR of 3.00 at P < 0.001.
Up nextJournal of bronchology & interventional pulmonologyJan 1, 2027Read
For interventional pulmonologists, remimazolam offers a favorable safety profile with significantly reduced respiratory depression (RR 0.51, 95% CI 0.36 to 0.73, P < 0.001) alongside rapid recovery and procedural efficiency.